SCHEMBL7642376

SCHEMBL7642376

CC(O)c1ccc2c(c1)Cc1ccccc1-2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 2/20 0.55
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
ALDH1A1 P00352 2/20 0.50
MAPT P10636 2/20 0.50
HPGD P15428 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
KDM4E B2RXH2 1/20 0.50
LMNA P02545 1/20 0.50
SRD5A2 P31213 1/20 0.49
CYP1A2 P05177 3/20 0.48
CYP3A4 P08684 2/20 0.48
HSD17B10 Q99714 2/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
HTR2C P28335 2/20 0.47
HTR2B P41595 2/20 0.47
MAOA P21397 2/20 0.47
ADRA2A P08913 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19383233 0.85 CYP17A1 (0.57) CYP17A1NPC1RAB9AALDH1A1MAPT
SCHEMBL8160351 0.85 CYP17A1 (0.57) CYP17A1NPC1RAB9AALDH1A1MAPT
SCHEMBL10900011 0.83 CYP17A1 (0.50) CYP17A1NPC1RAB9AALDH1A1MAPT
SCHEMBL7166658 0.82 CYP17A1 (0.55) CYP17A1NPC1RAB9AALDH1A1MAPT
SCHEMBL9261363 0.81 CYP17A1 (0.54) CYP17A1NPC1RAB9AALDH1A1MAPT
SCHEMBL28794469 0.81 SRD5A2 (0.53) CYP17A1NPC1RAB9AALDH1A1MAPT
SCHEMBL8610358 0.81 CYP17A1 (0.51) CYP17A1NPC1RAB9AALDH1A1MAPT
SCHEMBL7344324 0.81 CYP17A1 (0.51) CYP17A1NPC1RAB9AALDH1A1MAPT
SCHEMBL8606586 0.81 SRD5A2 (0.51) CYP17A1NPC1RAB9AALDH1A1MAPT
Cicloprofen SCHEMBL42839 0.80 PTGS2 (0.56) CYP17A1NPC1RAB9AMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6372930-B1 POLYMERIC LIGAND HAVING UNITS CONTAINING AT LEAST ONE BRIDGED CYCLOPENTADIENYL-TYPE GROUP INCLUDING AT LEAST ONE FLUORENYL-TYPE GROUP PHILLIPS PETROLEUM COMPANY 2002-04-16 US disclosed
US-6124414-A POLYMERIC METALLOCENE CATALYST WHICH IS PREPARED BY POLYMERIZING A 2-VINYLFLUORENE OR BY REACTING FLUORENE COMPOUND WITH CHLOROMETHYLMETHYLETHER, REACTING THE POLYMER WITH ALKALI METAL AND THEN WITH TRANSITIONAL METAL COMPOUND PHILLIPS PETROLEUM COMPANY (US) 2000-09-26 US disclosed
US-6090950-A Chiral hydride complexes ZEELAND CHEMICALS, INC. (US) 2000-07-18 US disclosed
US-6057410-A COMPLEXING FOR POLYMERIZATION CATALYSTS A PENTADIENYL LIGAND AND POLYMERIZATION WITH INITIATORS PHILLIPS PETROLEUM COMPANY (US) 2000-05-02 US disclosed
US-6040402-A PRODUCT OF REACTING A FLUORENYL-CONTAINING POLYMER WITH AN ALKALI METAL COMPOUND; AND REACTING THE PRODUCT OF STEP WITH A TRANSITION METAL-CONTAINING COMPOUND. PHILLIPS PETROLEUM COMPANY (US) 2000-03-21 US disclosed
US-5807880-A ANTICANCER AGENTS; DISEASES OF PROSTATE GLAND, MAMMARY GLANDS; ENDOMETRIOSIS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1998-09-15 US disclosed
US-5770755-A REACTION OF TRANSITION METAL COMPOUND WITH POLYMER CONTAINING CYCLOPENTADIENE, INDENE, OR FLUORENE GROUPS PHILLIPS PETROLEUM COMPANY (US) 1998-06-23 US disclosed
WO-1998007653-A1 CHIRAL HYDRIDE COMPLEXES ZEELAND CHEMICALS, INC. (US) 1998-02-26 WO disclosed
CN-1131944-A Azole derivative and pharmachutical composition thereof YAMANOUCHI PHARMACUETICAL CO L (JP) 1996-09-25 CN disclosed
EP-0721943-A1 AZOLE DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1996-07-17 EP disclosed